Carta Healthcare

Realyze Intelligence has developed a suite of tools to facilitate clinical trial matching & data abstraction – together these tools can: - Accelerate screening & matching of patients to oncology clinical trials - Provide auto-abstraction for Real World Data needs (registry, research, etc) - Identify care pathways and pathway adherence The Realyze solution enables clinical oncology research sites to increase enrollment, target more diverse populations and turbocharge clinical research capabilities using existing resources. Our goal is to be a force-multiplier for existing oncology clinical trial & research teams. The Realyze platform leverages a combination of AI, LLMs and clinically guided expert models to analyze EHR data in real time, instantly matching patients to clinical trials. Additionally, the solution captures and makes available all the key clinical data from the unstructured notes to allow it to be imported back into the EMR, improving research and other clinical uses. -- Realyze has provided a 5x increase in patient matching for oncology clinical trials, including expanding the target locations and demographics for the identified populations. -- Realyze has processed and analyzed over 3 million patient records and well over 10 million individual medical documents across 36 different source systems/EMRs. -- Clinical teams using the Realyze intelligence solution have seen a reduction in trial screening time from 1-2 hours to under a minute per patient. -- The Realyze solution augments existing workflows and integrates the data back into EMRs & CTMSs. -- The Realyze solution acts as a force-multiplier for your existing team – freeing them from the drudgery of screening & abstraction. -- The Realyze platform has been used to identify patients to optimize value-based care programs, registry entry, care coordination, & research. -- Realyze collaborates w. leading health systems such as Memorial Sloan Kettering Cancer Center, OneOncology & UPMC.